NCCAM on ephedra
This article was originally published in The Tan Sheet
Executive Summary
NIH center is considering sponsoring a case-control study on adolescents' use of ephedra for weight-loss and/or performance enhancement. Story on p. 9 of 1"The Tan Sheet" March 24, 2003 implied NCCAM would limit research to the herbal's use for performance enhancement...
You may also be interested in...
Ephedra Case-Control Study Supported By NCCAM Advisory Council
A motion recommending that NCCAM initiate a "case-control study...among adolescents and young adults using ephedra for performance enhancement" passed the center's National Advisory Council for Complementary & Alternative Medicine by a 7-3 vote
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.